Prostate cancer in Brazil and Latin America: epidemiology and screening

Rafael Rocha Tourinho-Barbosa, Antonio Carlos Lima Pompeo, Sidney Glina, Rafael Rocha Tourinho-Barbosa, Antonio Carlos Lima Pompeo, Sidney Glina

Abstract

Introduction: Prostate cancer is one of the tumors with higher incidence and mortality among men in the World. Epidemiological data are influenced by life expectancy of population, available diagnostic methods, correct collection of data and quality of health services. Screening of the disease is not standardized around the World. Up till now there is no consensus about the risks versus benefits of early detection. There are still missing data about this pathology in Latin America.

Objective: to revise current epidemiologic situation and early diagnosis policies of prostate cancer in Brazil and Latin America.

Materials and methods: Medline, Cochrane Library and SciELO databases were reviewed on the subject of epidemiology and screening of prostate cancer. Screening research was performed in websites on national public health organizations and Latin America. Screening recommendations were obtained from those governmental organizations and from Latin American urological societies and compared to the most prominent regulatory agencies and societies of specialists and generalists from around the World.

Results: Brazil and Latin America have a special position in relation to incidence and mortality of prostate cancer. In Brazil, it occupies the first position regarding incidence of cancer in men and the second cause of mortality. Central America has the highest rate of mortality of the continent with lower incidence/mortality ratios. Screening recommendations are very distinct, mainly among regulatory organs and urological societies.

Conclusion: prostate cancer epidemiology is an important health public topic. Data collection related to incidence and mortality is still precarious, especially in less developed countries. It is necessary to follow-up long term screening studies results in order to conclude its benefits.

Keywords: Epidemiology; Latin America; Prostatic Neoplasms.

Conflict of interest statement

Conflicts of Interest: None declared.

Copyright® by the International Brazilian Journal of Urology.

Figures

Figure 1. Incidence and mortality rates in…
Figure 1. Incidence and mortality rates in World per 100.000 inhabitants source: GLOBOCAN, 2012.
Figure 2. Crude rates of incidence of…
Figure 2. Crude rates of incidence of prostate cancer, per 100.000 men, estimated for the year 2014, according to Federation Units.
Figure 3. Mortality rates of prostate cancer,…
Figure 3. Mortality rates of prostate cancer, per 100.000 men, adjusted to World population. Brazil, 2012.
Figure 4. Incidence and mortality rates of…
Figure 4. Incidence and mortality rates of prostate cancer in each American country, 2012.
Figure 5. Estimate of new cases and…
Figure 5. Estimate of new cases and deaths due to prostate cancer in 2012 and 2030, in the Americas.
Figure 6. Incidence/mortality ratio of prostate cancer,…
Figure 6. Incidence/mortality ratio of prostate cancer, compared to gnp per capita per country, 2012.

References

    1. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11. Lyon, France: International Agency for Research on Cancer; 2013. [accessed on 07/08/2015]. [Internet] Available at. .
    1. Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, et al. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. Lancet. 2014;384:2027–2035.
    1. Andriole GL, Crawford ED, Grubb RL, 3rd, Buys SS, Chia D, Church TR, et al. Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up. J Natl Cancer Inst. 2012;104:125–132.
    1. Informativo detecção precoce . Instituto Nacional de Câncer José Alencar Gomes da Silva/Ministério da Saúde. Boletim ano 5. 2. Brasil: INCA; maio;agosto. 2014. Available at. .
    1. Faria EF, Carvalhal GF, Vieira RA, Silva TB, Mauad EC, Tobias-Machado M, et al. Comparison of clinical and pathologic findings of prostate cancers detected through screening versus conventional referral in Brazil. Clin Genitourin Cancer. 2011;9:104–108.
    1. Romero FR, Romero AW, Almeida RM, Tambara R., Filho The prevalence of prostate cancer in Brazil is higher in Black men than in White men: systematic review and meta-analysis. Int Braz J Urol. 2012;38:440–447.
    1. Glina S, Toscano IL, Júnior, Mello LF, Martins FG, Vieira VLA. Damas CGS: Results of screening for prostate câncer in a community hospital. Int Braz J Urol. 2001;27:235–243.
    1. Cancer in the Americas: country profiles 2013. Washington, D.C.: PAHO/WHO; 2013. [No authors] Available at. .
    1. Faria EF, Carvalhal GF, Vieira RA, Silva TB, Mauad EC, Carvalho AL. Program for prostate cancer screening using a mobile unit: results from Brazil. Urology. 2010;76:1052–1057.
    1. Nardi AC, Reis RB, Zequi Sde C, Nardozza A., Jr. Comparison of the epidemiologic features and patterns of initial care for prostate cancer between public and private institutions: a survey by the Brazilian Society of Urology. Int Braz J Urol. 2012;38:155–164.
    1. Tobias-Machado M, Carvalhal GF, Freitas CH, Jr, Reis RB, Reis LO, Nogueira L, et al. Association between literacy, compliance with prostate cancer screening, and cancer aggressiveness: results from a Brazilian screening study. Int Braz J Urol. 2013;39:328–334.
    1. Instituto Nacional del Cáncer . Ministerio de Salud de la Nación. Argentina: INC.; Available at. .
    1. Sistema General de Seguridad Social em Salud – Instituto Nacional de Cancerología / Sociedad Colombiana de Urologia. Guia n° GPC-2013-21. Colômbia: 2013. Guia de práctica clínica para la detección temprana, diagnóstico, tratamento, seguimento y rehabilitación del cáncer de próstata. Available at. .
    1. Niclis C, Pou SA, Bengió RH, Osella AR, Díaz Mdel P. Prostate cancer mortality trends in Argentina 1986-2006: an age-period-cohort and joinpoint analysis. Cad Saude Publica. 2011;27:123–130.
    1. NHScancer screening programmes. UK: NHS; 2015. Prostate cancer risk management programme: overview. Available at. .
    1. U. S. Preventive Services Task Force. USA: USPSTF; 2012. Screening for prostate cancer. Available at. .
    1. Canadian Task Force on Preventive Health Care. Canadá: CTFPHC; 2014. Screening for prostate cancer with prostate specific antigen recommendations 2014. Available at. .
    1. Instituto Nacional de Câncer José Alencar Gomes da Silva/Ministério da Saúde. Brasil: INCA; 2013. Rastreamento do câncer de próstata. Available at. .
    1. Diagnóstico y Tratamiento del Câncer de Próstata em um Segundo y Tercer Nível de Atención. Mexico: Secretaria de Salud; 2010. Available at. .
    1. Qaseem A, Barry MJ, Denberg TD, Owens DK, Shekelle P. Clinical Guidelines Committee of the American College of Physicians. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Ann Intern Med. 2013;158:761–769.
    1. Screening for prostate cancer: recommendation statement. Am Fam Physician. 2013;87(4) [No authors] online. Disponível em: .
    1. Carter HB, Albertsen PC, Barry MJ, Etzioni R, Freedland SJ, Greene KL, et al. Early Detection of prostate cancer: AUA guideline. American Urological Association. 2013 Available at. .
    1. American Cancer Society recommendations for prostate cancer early detection. American Cancer Society. (last revised 01/06/2015) Available at. .
    1. Mottet N, Bellmunt J, Briers E, van den Bergh RCN, Bolla M, van Casteren NJ, et al. Guidelines on prostate cancer. European Association of Urology. 2015
    1. Sociedade Brasileira de Urologia. 2013. Recomendações em câncer de próstata. Available at. .
    1. Sociedad Peruana de Urología. Peru: SPU; Guía para el diagnostico y tratamiento del cáncer de próstata. Available at. .
    1. Sociedad Mexicana de Urologia. Mexico: SMU; Manual de Salud Masculina. [No authors] Available at. .
    1. Consenso Nacional Inter-Sociedades para el Diagnóstico y Tratamiento del Cáncer de Próstata. Argentina: 2014. Available at. .

Source: PubMed

3
Abonner